EV/EBITDA:
-1.82+0.05(+2.67%)Summary
- As of today (September 8, 2025), NTLA EV/EBITDA is -1.82, with a rise of +0.05 (+2.67%) during the most recent trading session on September 8, 2025.
- Over the past year, NTLA EV/EBITDA has increased by +0.94 (+34.06%).
- NTLA EV/EBITDA is now -264.00% below its all-time high of -0.50.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.7% | -2.5% | -1.8% |
| 1 m1 month | -13.8% | +14.1% | +9.7% |
| 3 m3 months | -114.1% | +101.5% | +46.4% |
| 6 m6 months | -40.0% | +34.4% | +14.4% |
| ytdytd | -19.7% | +14.5% | +1.5% |
| 1 y1 year | +34.1% | -35.6% | -40.0% |
| 5 y5 years | +65.8% | +49.2% | -32.2% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.45 | -25.5% | -1.87 | +2.7% |
| 3 m | 3-month | -0.85 | -114.1% | -2.28 | +20.2% |
| 6 m | 6-month | -0.50 | -264.0% | -2.28 | +20.2% |
| 1 y | 1-year | -0.50 | -264.0% | -3.39 | +46.3% |
| 3 y | 3-year | -0.50 | -264.0% | -11.37 | +84.0% |
| 5 y | 5-year | -0.50 | -264.0% | -69.81 | +97.4% |
| alltime | all time | -0.50 | -264.0% | -69.81 | +97.4% |
NTLA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.82(+19.7%) |
| 2024 | -1.52(-62.3%) |
| 2023 | -4.03(-8.2%) |
| 2022 | -4.39(-85.9%) |
| 2021 | -31.16(+33.4%) |
| Date | Value |
|---|---|
| 2020 | -23.35(+395.8%) |
| 2019 | -4.71(+44.9%) |
| 2018 | -3.25(-54.4%) |
| 2017 | -7.12(+11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Intellia Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of NTLA is -1.82
What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high EV/EBITDA is -0.50
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics, Inc. EV/EBITDA has changed by -0.30 (-19.74%) since the beginning of the year
What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +0.94 (+34.06%)